Atopic dermatitis: From the genes to skin lesions

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 55, Issue 3, 2000, Pages 205-213

  Wollenberg, Andreas ^a   Bieber, T ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E;

ATOPIC DERMATITIS; GENETIC LINKAGE; GENETIC POLYMORPHISM; HUMAN; IMMUNOGLOBULIN PRODUCTION; IMMUNOHISTOLOGY; IMMUNOPATHOGENESIS; KERATINOCYTE; MAST CELL; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRICK TEST; PRIORITY JOURNAL; RADIOALLERGOSORBENT TEST; REVIEW; SKIN ALLERGY;

DERMATITIS, ATOPIC; HUMANS; SKIN;

EID: 0034059476     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2000.00115.x     Document Type: Review

References (101)

1. RING J. Erstbeschreibung einer atopischen Familien-Anamnese im Julisch-Claudischen Kaiserhaus: Augustus, Claudius, Britannicus. Hautarzt 1985;36:470-474.
2. LAPIDUS CS, SCHWARZ DF, HONIG PJ. Atopic dermatitis in children: who cares? who pays? J Am Acad Dermatol 1993;28:699-703.
3. GRANLUND H, ERKKO P, SINISALO M, REITAMO S. Cyclosporin in atopic dermatitis: time to relapse and effect of intermittent therapy. Br J Dermatol 1995;132:106-112.
4. GIELER U, HOHMANN M, NIEMEIER V,KUPHER J, STANGIER U, EHLERS A. Cost evaluation in atopic eczema. J Dermatol Treat 1999;10:S15-S25.
5. COCA A, COOKE R. On the classification of the phenomena of hypersensitivity. J Immunol 1923;8:163-182.
6. RÖCKEN M, SCHALLREUTHER K, RENZ H, SZENTIVANYI A. What exactly is atopy? Exp Dermatol 1998;7:97-104.
7. RAJKA G. Essential aspects of atopic dermatitis. Berlin: Springer, 1989.
8. RUZICKA T, RING J, PRZYBILLA B. Handbook of atopic dermatitis. Berlin: Springer, 1991.
9. PRZYBILLA B, EBERLEIN-KONIG B, RUEFF F. Practical management of atopic eczema. Lancet 1994;343:1342-1346.
10. COOPER KD. Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol 1994;102:128-137.
11. BOS JD, KAPSENBERG ML, SMITT JH. Pathogenesis of atopic eczema. Lancet 1994;343:1338-1341.
12. LEUNG DY. Pathogenesis of atopic dermatitis. J Allergy Clin Immunol 1999;104:S99-108.
13. εRI-expressing antigen- presenting cells: new players in the atopic game. Immunol Today 1997;18:311-313.
14. VALENTA R, NATTER S, SEIBERLER S, et al. Molecular characterization of an autoallergen, Hom s 1, identified by serum IgE from atopic dermatitis patients. J Invest Dermatol 1998;111:1178-1183.
15. WOLLENBERG A, BIEBER T. FK-506/tacrolimus. In: BURG G, DUMMER RG, editors. Strategies for immunointerventions in dermatology. Berlin: Springer, 1997:53-57.
16. VAN LEENT EJ, GRABER M, THURSTON M, WAGENAAR A, SPULS PI, BOS JD. Effectiveness of the ascomycin macrolactam SDZ ASM 981 in the topical treatment of atopic dermatitis. Arch Dermatol 1998;134:805-809.
17. RUZICKA T, ASSMANN T, HOMEY B. Tacrolimus - the drug for the turn of the millennium? Arch Dermatol 1999;135:574-580.
18. UEHARA M. Dry skin and inflammation. In: RUZICKA T, RING J, PRZYBILLA B, editors. Handbook of atopic dermatitis. Berlin: Springer, 1991:84-89.
19. PRZYBILLA B, RING J, ENDERS F, WINKELMANN H. Stigmata of atopic constitution in patients with atopic eczema or atopic respiratory disease. Acta Derm Venereol 1991;71:407-410.
20. PRZYBILLA B, RING J, VÖLK M. Gesamt-IgE-Spiegel im Serum bei dermatologischen Erkrankungen. Hautarzt 1986;37:77-82.
21. MORREN MA, PRZYBILLA B, BAMELIS M, HEYKANTS B, REYNAERS A, DEGREEF H. Atopic dermatitis: triggering factors. J Am Acad Dermatol 1994;31:467-473.
22. HANIFIN JM, RAJKA G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) Suppl 1980;92:44-47.
23. DIEPGEN TL, SAUERBREI W, FARTASCH M. Development and validation of diagnostic scores for atopic dermatitis incorporating criteria of data quality and practical usefulness. J Clin Epidemiol 1996;49:1031-1038.
24. WILLIAMS HC, BURNEY PG, HAY RJ, et al. Working party's diagnostic criteria for atopic dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol 1994;131:383-396.
25. WILLIAMS HC, BURNEY PGJ, PEMBROKE AC, HAY RJ. The U.K. working party's diagnostic criteria for atopic dermatitis. III. Independent hospital validation. Br J Dermatol 1994;13:406-416.
26. FIROOZ A, DAVOUDI SM, FARAHMAND AN, MAJDZADEH R, KASHANI MN, DOWLATI Y. Validation of the diagnostic criteria for atopic dermatitis. Arch Dermatol 1999;135:514-516.
27. BOS JD, VAN LEENT EJ, SILLEVIS SMITT JH. The millennium criteria for the diagnosis of atopic dermatitis. Exp Dermatol 1998;7:132-138.
28. WÜTHRICH B. Neurodermitis atopica. Wien Med Wochenschr 1989;139:156-65.
29. AKDIS CA, AKDIS M, SIMON D, et al. Role of T cells and cytokines in the intrinsic form of atopic dermatitis. Curr Probl Dermatol 1999;28:37-44.
30. εRI on epidermal dendritic cells. Arch Dermatol Res 2000;292:108.
31. SCHULTZ LARSEN F, HANIFIN JM. Secular change in the occurrence of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1992;176:7-12.
32. TAYLOR B, WADSWORTH J, WADSWORTH M, PECKHAM C. Changes in the reported prevalence of childhood eczema since the 1939-45 war. Lancet 1984;2:1255-1257.
33. NINAN TK, RUSSELL G. Respiratory symptoms and atopy in Aberdeen schoolchildren: evidence from two surveys 25 years apart. BMJ 1992;304:873-875.
34. EATON KK. The incidence of allergy has it changed? Clin Allergy 1982;12:107-110.
35. OLESEN AB, ELLINGSEN AR, LARSEN FS, et al. Atopic dermatitis may belinked to whether a child is first- or second- born and/or the age of the mother. Acta Derm Venereol 1996;76:457-460.
36. WJST M, DOLD S, REITMEIER P, WULFF A, NICOLAI T, VON MUTIUS E. Schützt Stillen vor Asthma und Allergien? Ergebnisse der Münchner Asthma- und Allergiestudie. Monatsschr Kinderheilkd 1992;140:769-774.
37. ISOLAURI E, TAHVANAINEN A, PELTOLA T, ARVOLA T. Breast-feeding of allergic infants. J Pediatr 1999;134:27-32.
38. COGSWELL JJ, MITCHELL EB, ALEXANDER J. Parental smoking, breast feeding, and respiratory infection in development of allergic diseases. Arch Dis Child 1987;62:338-344.
39. SHOHET L, SHAHAR E, DAVIDSON S. Breast feeding as prophylaxis for atopic eczema: a controlled study of 368 cases. Acta Paediatr Hung 1985;26:35-39.
40. VON MUTIUS E. The rising trends in asthma and allergic disease. Clin Exp Allergy 1998;28 Suppl 5:45-49.
41. ECKERT F. Histopathological and immunohistological aspects of atopic dermatitis. In: RUZICKA T, RING J, PRZYBILLA B, editors. Handbook of atopic dermatitis. Berlin: Springer, 1991:127-131.
42. ACKERMAN AB. Histologic diagnosis of inflammatory skin diseases. Philadelphia: Lea and Febiger, 1978.
43. LEVER W, SCHAUMBURG-LEVER G. Histopathology of the skin. Philadelphia: Lippincott, 1990.
44. WOLLENBERG A, WEN S, BIEBER T. Langerhans cell phenotyping: a new tool for differential diagnosis of inflammatory skin diseases. Lancet 1995;346:1626-1627.
45. WOLLENBERG A, WEN S, BIEBER T. Phenotyping of epidermal dendritic cells clinical applications of a flow cytometric micromethod. Cytometry 1999;37:147-155.
46. WOLLENBERG A, KRAFT S, HANAU D, BIEBER T. Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema. J Invest Dermatol 1996;106:446-453.
47. BOS JD. Skin immune system (SIS). Boca Raton, FL: CRC Press, 1997.
48. BIEBER T, WOLLENBERG A. Skin as an immunocompetent organ in health and disease. In: BURG G, DUMMER RG, editors. Strategies for immunoinlerventions in dermatology. Berlin: Springer, 1997:21-28.
49. AGOSTI JM, SPRENGER JD, LUM LG, et al. Transfer of allergen-specific IgE-mediated hypersensitivity with allogeneic bone marrow transplantation. N Engl J Med 1988;319:1623-1628.
50. SCHULTZ-LARSEN F, HOLM NV, HENIGSEN K. Atopic dermatitis: a genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol 1986;15:487-494.
51. COLEMAN R, TREMBATH RC, HARPER JI. Genetic studies of atopy and atopic dermatitis. Br J Dermatol 1997;136:1-5.
52. MARSH DG, MEYERS DA, BIAS WB. The epidemiology and genetics of atopic allergy. N Engl J Med 1981;305:1551-1559.
53. SZENTIVANYI A. The beta adrenergic theory of the atopic abnormality in asthma. J Allergy 1968;42:203.
54. DE LA CUESTA CG, SANZ ML, GAMBOA PM, DIEGUEZ I, OEHLING A. Modulation of beta 2-adrenoceptors in lymphocytes of allergic patients after in vitro antigenic stimulation. J Investig Allergol Clin Immunol 1993;3:130-135.
55. DOULL IJ, LAWRENCE S, WATSON M, et al. Allelic association of gene markers on chromosomes 5q and 11q with atopy and bronchial hyperresponsiveness. Am J Respir Crit Care Med 1996;153:1280-1284.
56. BLUMENTHAL MN, WANG Z, WEBER JL, RICH SS. Absence of linkage between 5q markers and serum TgE levels in four large atopic families. Clin Exp Allergy 1996;26:892-896.
57. COOKSON WO, SHARP PA, FAUX JA, HOPKIN JM. Linkage between immunoglobulin E responses underlying asthma and rhinitis and chromosome 11q. Lancet 1989;i:1292-1295.
58. FOLSTER HOLST R, MOISES HW, YANG L, FRITSCH W, Weissenbach J, Christophers E. Linkage between atopy and the IgE high-affinity receptor gene at 11q13 in atopic dermatitis families. Hum Genet 1998;102:236-239.
59. HIZAWA N, YAMAGUCHI E, OHE M, et al. Lack of linkage between atopy and locus 11q13. Clin Exp Allergy 1992;22:1065-1069.
60. COLEMAN R, TREMBATH RC, HARPER JI. Chromosome 11q13 and atopy underlying atopic eczema. Lancet 1993;341:1121-1122.
61. MAO XQ, SHIRAKAWA T, YOSHIKAWA T, et al. Association between genetic variants of mast-cell chymase and eczema. Lancet 1996;348:581-583.
62. TANAKA K, SUGIURA H, UEHARA M, et al. Association between mast cell chymase genotype and atopic eczema: comparison between patients with atopic eczema alone and those with atopic eczema and atopic respiratory disease. Clin Exp Allergy 1999;29:800-803.
63. KAWASHIMA T, NOGUCHI E, ARINAMI T, KOBAYASHI K, OTSUKA K, HAMAGUCHI H. No evidence for an association between a variant of the mast cell chymase gene and atopic dermatitis based on case-control and haplotype- relative-risk analyses. Hum Hered 1998;48:271-274.
64. DEICHMANN KA, HEINZMANN A, FORSTER J, et al. Linkage and allelic association of atopy and markers flanking the IL4-receptor gene. Clin Exp Allergy 1998;28:151-155.
65. PRITCHARD MA, BAKER E, WHITMORE SA, et al. The interleukin-4 receptor gene (IL4R) maps to 16p11.2-16p12.1 in human and to the distal region of mouse chromosome 7. Genomics 1991;10:801-806.
66. HERSHEY GK, FRIEDRICH MF, ESSWEIN LA, THOMAS ML, CHATILA TA. The association of atopy with a gain-of- function mutation in the alpha subunit of the interleukin-4 receptor [see comments]. N Engl J Med 1997;337:1720-1725.
67. KRUSE S, JAPHA T, TEDNER M, et al. The polymorphisms S503P and Q576R in the interleukin-4 receptor alpha gene are associated with atopy and influence the signal transduction. Immunology 1999;96:365-371.
68. MANKU MS, HORROBIN DF, MORSE N, et al. Reduced levels of prostaglandin precursors in the blood of atopic patients: defective delta-6-desaturase function as a biochemical basis for atopy. Prostaglandins Leukot Med 1982;9:615-628.
69. YU G, BJÖRKSTÉN B. Polyunsaturated fatty acids in schoolchildren in relation to allergy and serum IgE levels. Pediatr Allergy Immunol 1998;9:133-138.
70. HANIFIN J. Atopic dermatitis and other endogenous eczemas. Semin Dermatol 1983;2:1-44.
71. HANIFIN JM, CHAN SC. Monocyte phosphodiesterase abnormalities and dysregulation of lymphocyte function in atopic dermatitis. J Invest Dermatol 1995;105:84s-88s.
72. HANIFIN JM, CHAN SC, CHENG JB, et al. Type 4 phosphodiesterase inhibitors have clinical and in vitro anti- inflammatory effects in atopic dermatitis. J Invest Dermatol 1996;107:51-56.
73. MOSMANN TR, SAD S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996;17:138-146.
74. SUGIURA H, UEHARA M. Mitosis of mast cells in skin lesions of atopic dermatitis. Acta Derm Venereol 1993;73:296-299.
75. HORSMANHEIMO L, HARVIMA IT, JARVIKALLIO A, HARVIMA RJ, NAUKKARINEN A, HORSMANHEIMO M. Mast cells are one major source of interleukin-4 in atopic dermatitis. Br J Dermatol 1994;131:348-353.
76. JARVIKALLIO A, NAUKKARINEN A, HARVIMA IT, AALTO ML, HORSMANHEIMO M. Quantitative analysis of tryptase- and chymase- containing mast cells in atopic dermatitis and nummular eczema. Br J Dermatol 1997;136:871-877.
77. PASTORE S, FANALES BELASIO E, ALBANESI C, CHINNI LM, GIANNETTI A, GIROLOMONI G. Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. Implications for sustained dendritic cell activation in the skin. J Clin Invest 1997;99:3009-3017.
78. PIRRON U, SCHLUNCK T, PRINZ JC, RIEBER EP. IgE-dependent antigen focusing by human B lymphocytes is mediated by the low-affinity receptor for IgE. Eur J Immunol 1990;20:1547-1551.
79. VAN DER HEIJDEN FL, VAN NEERVEN RJJ, VAN KATWIJK M, BOS JD, KAPSENBERG ML. Serum-IgE-facilitated allergen presentation in atopic disease. J Immunol 1993;150:3643-3650.
80. εRIγ-chains and can use this receptor for IgE-mediated allergen presentation. J Immunol 1996;157:607-616.
81. εR2/CD23 on human epidermal Langerhans cells by human recombinant interleukin-4 and gamma Interferon. J Exp Med 1989;170:309-314.
82. εRI). J Exp Med 1992;175:1285-1290.
83. εRI. J Exp Med 1992;175:1353-1365.
84. GRABBE J, HAAS N, HAMANN K, KOLDE G, HAKIMI J, CZARNETZKI B. Demonstration of the high-affinity IgE receptor on human Langerhans cells in normal and diseased skin. Br J Dermatol 1993;129:120-123.
85. WOLLENBERG A, DE LA SALLE H, HANAU D, LIU FT, BIEBER T. Human keratinocytes release the endogenous β-galactoside-binding soluble lectin εBP which binds to Langerhans cells where it modulates their binding capacity for IgE glycoforms. J Exp Med 1993;178:777-785.
86. KLUBAL R, OSTERHOFF B, WANG B, KINET JP, MAURER D, STINGL G. The high-affinity receptor for IgE is the predominant IgE-binding structure in lesional skin of atopic dermatitis patients. J Invest Dermatol 1997;108:336-342.
87. TAYLOR RS, BAADSGAARD O, HAMMERBERG C, COOPER KD. Hyperstimulatory CD1a+CD1b+CD36+ Langerhans cells are responsible for increased autologous T lymphocyte reactivity to lesional epidermal cells of patients with atopic dermatitis. J Immunol 1991;147:3794-3802.
88. WOLLENBERG A, BIEBER T. Two populations of CD1a+ epidermal dendritic cells expressing B7 molecules in human skin. Br J Dermatol 1998;138:358-359.
89. GREWE M, CZECH W, MORITA A, et al. Human eosinophils produce biologically active IL-12: implications for control of T cell responses. J Immunol 1998;161:415-420.
90. DARSOW U, VIELUF D, RING J. Evaluating the relevance of aeroallergen sensitization in atopic eczema with the atopy patch test: a randomized, double-blind multicenter study. Atopy Patch Test Study Group. J Am Acad Dermatol 1999;40:187-193.
91. LEUNG DY, HAUK P, STRICKLAND I, TRAVERS JB, NORRIS DA. The role of superantigens in human diseases: therapeutic implications for the treatment of skin diseases. Br J Dermatol 1998;139 Suppl 53:17-29.
92. ABECK D, MEMPEL M. Staphylococcus aureus colonization in atopic dermatitis and its therapeutic implications. Br J Dermatol 1998;139 Suppl 53:13-16.
93. HOSOI J, MURPHY GF, EGAN CL, et al. Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature 1993;363:159-163.
94. SCHAUER E, TRAUTINGER F, KOCK A, et al. Proopiomelanocortin-derived peptides are synthesized and released by human keratinocytes. J Clin Invest 1994;93:2258-2262.
95. LAMBERT RW, GRANSTEIN RD. Neuropeptides and Langerhans cells. Exp Dermatol 1998;7:73-80.
96. PRINZ B, NACHBAR F, PLEWIG G. Treatment of severe atopic dermatitis with extracorporeal photopheresis. Arch Dermatol Res 1994;287:48-52.
97. WAKIM M, ALAZARD M, YAJIMA A, SPEIGHTS D, SAXON A, STIEHM ER. High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome. Ann Allergy Asthma Immunol 1998;81:153-158.
98. BORNHÖVD EC, SCHULLER E, BIEBER T, WOLLENBERG A. Immunsuppressive Makrolide und ihr Einsatz in der Dermatologie. Hautarzt 2000 (in press).
99. MEINGASSNER JG, GRASSBERGER M, FAHRNGRUBER H, MOORE HD, SCHUURMAN H, STÜTZ A. A novel anti- inflammatory drug, SDZ ASM 981, for the topical and oral treatment of skin diseases: in vivo pharmacology. Br J Dermatol 1997;137:568-576.
100. RUZICKA T, BIEBER T, SChÖPF E, et al. A short-term trial of tacrolimus ointment for atopic dermatitis. N Engl J Med 1997;337:816-821.
101. REITAMO S, WOLLENBERG A, SCHÖPF E, et al. Long-term efficacy and safety of tacrolimus ointment in adult patients with atopic dermatitis. Arch Dermatol 2000 (in press).